103 related articles for article (PubMed ID: 9539190)
1. Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol.
Michnovicz JJ
Int J Obes Relat Metab Disord; 1998 Mar; 22(3):227-9. PubMed ID: 9539190
[TBL] [Abstract][Full Text] [Related]
2. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol.
Michnovicz JJ; Bradlow HL
Nutr Cancer; 1991; 16(1):59-66. PubMed ID: 1656396
[TBL] [Abstract][Full Text] [Related]
3. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
[TBL] [Abstract][Full Text] [Related]
4. Urinary markers of estrogen metabolism 2- and 16 alpha-hydroxylation in premenopausal women.
Pasagian-Macaulay A; Meilahn EN; Bradlow HL; Sepkovic DW; Buhari AM; Simkin-Silverman L; Wing RR; Kuller LH
Steroids; 1996 Aug; 61(8):461-7. PubMed ID: 8870165
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte-derived factor as a modulator of oxidative estrogen metabolism: implications for obesity and estrogen-dependent breast cancer.
Bradlow HL; Sepkovic DW; Telang N; Tiwari R
In Vivo; 2011; 25(4):585-8. PubMed ID: 21709000
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole fails to alter the cytochrome P450-dependent 2-hydroxylation of estradiol in male volunteers.
Galbraith RA; Michnovicz JJ
Pharmacology; 1993 Jul; 47(1):8-12. PubMed ID: 8337235
[TBL] [Abstract][Full Text] [Related]
7. Increased urinary catechol estrogen excretion in female smokers.
Michnovicz JJ; Naganuma H; Hershcopf RJ; Bradlow HL; Fishman J
Steroids; 1988; 52(1-2):69-83. PubMed ID: 2854668
[TBL] [Abstract][Full Text] [Related]
8. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans.
Michnovicz JJ; Adlercreutz H; Bradlow HL
J Natl Cancer Inst; 1997 May; 89(10):718-23. PubMed ID: 9168187
[TBL] [Abstract][Full Text] [Related]
9. Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity.
McAlindon TE; Gulin J; Chen T; Klug T; Lahita R; Nuite M
Lupus; 2001; 10(11):779-83. PubMed ID: 11789487
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
[TBL] [Abstract][Full Text] [Related]
11. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
[TBL] [Abstract][Full Text] [Related]
12. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer.
Dalessandri KM; Firestone GL; Fitch MD; Bradlow HL; Bjeldanes LF
Nutr Cancer; 2004; 50(2):161-7. PubMed ID: 15623462
[TBL] [Abstract][Full Text] [Related]
13. Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women.
Matthews CE; Fortner RT; Xu X; Hankinson SE; Eliassen AH; Ziegler RG
J Clin Endocrinol Metab; 2012 Oct; 97(10):3724-33. PubMed ID: 22855335
[TBL] [Abstract][Full Text] [Related]
14. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation.
Jellinck PH; Forkert PG; Riddick DS; Okey AB; Michnovicz JJ; Bradlow HL
Biochem Pharmacol; 1993 Mar; 45(5):1129-36. PubMed ID: 8384853
[TBL] [Abstract][Full Text] [Related]
15. Estrogen metabolism and human papillomavirus-induced tumors of the larynx: chemo-prophylaxis with indole-3-carbinol.
Newfield L; Goldsmith A; Bradlow HL; Auborn K
Anticancer Res; 1993; 13(2):337-41. PubMed ID: 8390800
[TBL] [Abstract][Full Text] [Related]
16. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
Ruan X; Seeger H; Wallwiener D; Huober J; Mueck AO
Arch Gynecol Obstet; 2015 May; 291(5):1141-6. PubMed ID: 25318606
[TBL] [Abstract][Full Text] [Related]
17. Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma.
Choi MH; Moon JY; Cho SH; Chung BC; Lee EJ
BMC Cancer; 2011 Aug; 11():342. PubMed ID: 21824401
[TBL] [Abstract][Full Text] [Related]
18. Alterations of estrogen metabolism in systemic lupus erythematosus.
Lahita RG; Bradlow HL; Kunkel HG; Fishman J
Arthritis Rheum; 1979 Nov; 22(11):1195-8. PubMed ID: 508372
[TBL] [Abstract][Full Text] [Related]
19. Induction of estradiol metabolism by dietary indole-3-carbinol in humans.
Michnovicz JJ; Bradlow HL
J Natl Cancer Inst; 1990 Jun; 82(11):947-9. PubMed ID: 2342128
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis.
Rosen CA; Woodson GE; Thompson JW; Hengesteg AP; Bradlow HL
Otolaryngol Head Neck Surg; 1998 Jun; 118(6):810-5. PubMed ID: 9627242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
